Misty Gamble
Georgetown University Hospital, USA
Posters & Accepted Abstracts: Primary Health Care
The treatment of advanced stage mycosis fungoides is especially challenging as single agent overall response rates are in the 35% range and chronic recurrence is the rule. The treatment of cutaneous T-cell lymphoma (CTCL) across all stages of disease is aimed at the goal of achieving and sustaining remission. Increasingly, low dose total skin electron beam therapy (TSEBT) is being utilized as a skin directed component in combination therapy for advanced stage CTCL. Researchers are seeking to better define the utility of low dose TSEBT as a method of de-bulking skin disease while simultaneously treating other disease compartments and in combination with sustained maintenance therapies of both the skin directed and systemic varieties. Data exists showing the efficacy of low dose TSEBT in early and advanced disease. There is also data documenting prolonged treatment responses with TSEBT plus adjuvant skin directed therapies such as PUVA and topical nitrogen mustard. Emerging data examining the role of low dose TSEBT in the prestem cell transplant preparation is also promising. This brief review summarizes the utility of low dose TSEBT in multi-agent treatment regimens in CTCL.
Email: gamblemf@yahoo.com
